We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$117B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
45.31%
Holding
3,828
New
377
Increased
1,948
Reduced
1,225
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$499M |
| 2 |
Vanguard Total Bond Market
BND
|
+$461M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$292M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$289M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$336M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$135M |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$82.5M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$81.2M |
| 5 |
JPMorgan BetaBuilders US Equity ETF
BBUS
|
+$70.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Financials | 3.7% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.73% |
| 5 | Healthcare | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Willamette Valley Vineyards
WVVI
$13.5M
| $86.1K | ﹤0.01% |
15,600
| – | – |
|
3452
AXT Inc
AXTI
$3.09B
| $85.9K | ﹤0.01% |
+41,123
| New | +$63.9K |
|
3453
BlackRock TCP Capital
TCPC
$265M
| $85.2K | ﹤0.01% |
+11,062
| New | +$81.2K |
|
3454
MeiraGTx Holdings
MGTX
$1.09B
| $83.3K | ﹤0.01% |
12,771
-25,461
| -67% | -$150K |
|
3455
Olema Pharmaceuticals
OLMA
$1.02B
| $83.2K | ﹤0.01% |
+19,521
| New | +$87K |
|
3456
Heron Therapeutics
HRTX
$86.3M
| $81.5K | ﹤0.01% |
39,389
-59,063
| -60% | -$121K |
|
3457
Abeona Therapeutics
ABEO
$345M
| $81.3K | ﹤0.01% |
14,310
+4,305
| +43% | +$24.5K |
|
3458
Atea Pharmaceuticals
AVIR
$379M
| $80.4K | ﹤0.01% |
22,341
| – | – |
|
3459
Baytex Energy
BTE
$3.08B
| $79.2K | ﹤0.01% |
44,248
-179
| -0.4% | -$313 |
|
3460
Strive Inc
ASST
$961M
| $78.8K | ﹤0.01% |
+1,050
| New | +$84.9K |
|
|
MCW
3461
DELISTED
Mister Car Wash
MCW
| $77.7K | ﹤0.01% |
12,930
-8,031
| -38% | -$56.4K |
|
3462
IHS Holding
IHS
$2.77B
| $77.1K | ﹤0.01% |
13,869
| – | – |
|
3463
Nuvation Bio
NUVB
$2.24B
| $76.6K | ﹤0.01% |
39,288
+28,585
| +267% | +$59.5K |
|
|
OPTU
3464
Optimum Communications Inc
OPTU
$316M
| $76.5K | ﹤0.01% |
35,743
+65
| +0.2% | +$152 |
|
3465
Braskem
BAK
$980M
| $76K | ﹤0.01% |
23,176
+2,062
| +10% | +$7.47K |
|
3466
ClearSign Technologies
CLIR
$22M
| $75.9K | ﹤0.01% |
14,185
| – | – |
|
3467
TMC The Metals Company
TMC
$1.59B
| $75.7K | ﹤0.01% |
+11,476
| New | +$44K |
|
3468
Allogene Therapeutics
ALLO
$601M
| $75.4K | ﹤0.01% |
66,744
-30,312
| -31% | -$40.3K |
|
3469
Getty Images
GETY
$184M
| $74.8K | ﹤0.01% |
+45,034
| New | +$79.4K |
|
3470
Wave Life Sciences
WVE
$1.12B
| $74.6K | ﹤0.01% |
11,484
+861
| +8% | +$5.69K |
|
3471
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $74.4K | ﹤0.01% |
+400
| New | +$229K |
|
|
ATYR
3472
aTyr Pharma
ATYR
$46.4M
| $73.6K | ﹤0.01% |
+14,509
| New | +$57.1K |
|
3473
Standard BioTools
LAB
$326M
| $73.3K | ﹤0.01% |
61,102
+22,082
| +57% | +$24.5K |
|
3474
Stagwell
STGW
$1.84B
| $71.9K | ﹤0.01% |
15,982
-50,040
| -76% | -$252K |
|
|
KEEL
3475
Keel Infrastructure Corp
KEEL
$2.57B
| $71.9K | ﹤0.01% |
85,580
+30,000
| +54% | +$27.7K |
|
Similar funds
Creative Planning's Q2 2025 Portfolio in Review
As of Q2 2025, Creative Planning held 3,828 positions worth $117B, up 10% from $106B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning's Q2 2025 filing shows 377 new, 1,948 increased, 1,225 reduced and 150 closed positions. Its largest new stake was CoreWeave: 140,135 shares worth $22.9M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $336M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q2 2025 buy was CoreWeave: 140,135 shares worth $22.9M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q2 2025, an estimated $499M increase.
- Creative Planning's biggest Q2 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $336M.
- Creative Planning fully exited Discover Financial Services in Q2 2025, selling an estimated $12.3M.
- Creative Planning's ten largest holdings make up 45% of its $117B portfolio in Q2 2025.
- Creative Planning opened 377 new positions and closed 150 in Q2 2025.
- Creative Planning's portfolio value rose 10% quarter-over-quarter to $117B.
Based on Creative Planning's 13F filing for Q2 2025, filed 8 Aug 2025.